References

References

  1. Graph adapted from the combination of the following publications: Rippe et al., Kidney Int., 2000; 57:2546-2556 & Rippe et al., Kidney Int., 1999; 40:315-325
  2. Woodrow G, Stables G, Oldroyd B, Gibson J, Turney JH, Brownjohn AM. Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis. Nephrol Dial Transplant. 1999;14:1530-1535.
  3. Mistry CD, Gokal R, Peers E, MIDAS Study Group. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD.  Kidney Int. 1994; 46: 496-503
  4. Wolfson M, Piraino B, Hamburger RJ, Mortin AR, for the Icodextrin Study Group. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis. 2002;40:1055-1065.
  5. Plum J, Gentile S, Verger C, et al. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.  Am J Kidney Dis. 2002;39:862-871
  6. Finkelstein F, Healy H, Abu-Alfa A, et al. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol. 2005;16:546-554.
  7. Davies SJ, Woodrow G, Donovan K, et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol. 2003;14:2338-2344.
  8. Holmes C, Mujais S.  Glucose sparing in peritoneal dialysis: Implications and metrics. Kidney Int. 2006: 70, S104-S109

 

 

 English | Español | Português